Concise review: MicroRNAs as modulators of stem cells and angiogenesis

Stem Cells

Volumn 32, Issue 5, 2014, Pages 1059-1066

  Kane, Nicole M ^a   Thrasher, Adrian J ^a   Angelini, Gianni D ^b,c   Emanueli, Costanza ^b,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Angiogenesis; Cellular therapy; Differentiation; Embryonic stem cells; Endothelial cell; Endothelial differentiation; miRNA; Vascular Progenitor cells

Indexed keywords

ANTAGOMIR; GROWTH FACTOR; MICRORNA; UNTRANSLATED RNA;

ANGIOGENESIS; BLOOD VESSEL; CELL THERAPY; CELL TYPE; CLINICAL TRIAL (TOPIC); ENDOTHELIUM CELL; GENE CONTROL; GENE EXPRESSION; GENE TARGETING; HOMEOSTASIS; HUMAN; ISCHEMIA; NONHUMAN; PLURIPOTENT STEM CELL; REGENERATION; REVIEW; STEM CELL; VASCULAR SURGERY; ANIMAL; BIOLOGICAL MODEL; CELL DIFFERENTIATION; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY);

ANIMALS; CELL DIFFERENTIATION; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; MODELS, GENETIC; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; STEM CELLS;

EID: 84899005497     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1629     Document Type: Review

References (73)

1. Bartel DP,. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
2. Yang JS, Maurin T, Lai EC,. Functional parameters of Dicer-independent microRNA biogenesis. RNA 2012; 18: 945-957.
3. Fazi F, Nervi C,. MicroRNA: Basic mechanisms and transcriptional regulatory networks for cell fate determination. Cardiovasc Res 2008; 79: 553-561.
4. Maher B,. ENCODE: The human encyclopaedia. Nature 2012; 489: 46-48.
5. Liu N, Olson EN,. MicroRNA regulatory networks in cardiovascular development. Dev Cell 2010; 18: 510-525.
6. Carmeliet P, Jain RK,. Molecular mechanisms and clinical applications of angiogenesis. Nature 2011; 473: 298-307.
7. Collet G, Skrzypek K, Grillon C, et al. Hypoxia control to normalize pathologic angiogenesis: Potential role for endothelial precursor cells and miRNAs regulation. Vascul Pharmacol 2012; 56: 252-261.
8. Yang WJ, Yang DD, Na S, et al. Dicer is required for embryonic angiogenesis during mouse development. J Biol Chem 2005; 280: 9330-9335.
9. Suarez Y, Fernandez-Hernando C, Pober JS, et al. Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells. Circ Res 2007; 100: 1164-1173.
10. Wang S, Olson EN,. AngiomiRs-Key regulators of angiogenesis. Curr Opin Genet Dev 2009; 19: 205-211.
11. Voellenkle C, Rooij J, Guffanti A, et al. Deep-sequencing of endothelial cells exposed to hypoxia reveals the complexity of known and novel microRNAs. RNA 2012; 18: 472-484.
12. Caporali A, Emanueli C,. MicroRNAs in postischemic vascular repair. Cardiol Res Pract 2012; 2012: 486702.
13. Howard L, Kane NM, Milligan G, et al. MicroRNAs regulating cell pluripotency and vascular differentiation. Vascul Pharmacol 2011; 55: 69-78.
14. Santoro MM, Nicoli S,. miRNAs in endothelial cell signaling: The endomiRNAs. Exp Cell Res 2013; 319: 1324-1330.
15. Mendell JT,. miRiad roles for the miR-17-92 cluster in development and disease. Cell 2008; 133: 217-222.
16. Dews M, Homayouni A, Yu D, et al. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet 2006; 38: 1060-1065.
17. Bonauer A, Carmona G, Iwasaki M, et al. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 2009; 324: 1710-1713.
18. Doebele C, Bonauer A, Fischer A, et al. Members of the microRNA-17-92 cluster exhibit a cell-intrinsic antiangiogenic function in endothelial cells. Blood 2010; 115: 4944-4950.
19. Lee DY, Deng Z, Wang C-H, et al. MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression. Proc Natl Acad Sci USA 2007; 104: 20350-20355.
20. Würdinger T, Tannous BA, Saydam O, et al. miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. Cancer Cell 2008; 14: 382-393.
21. Anand S, Majeti BK, Acevedo LM, et al. MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis. Nat Med 2010; 16: 909-914.
22. Suárez Y, Fernández-Hernando C, Yu J, et al. Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis. Proc Natl Acad Sci USA 2008; 105: 14082-14087.
23. Wang S, Aurora AB, Johnson BA, et al. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell 2008; 15: 261-271.
24. Fiedler J, Jazbutyte V, Kirchmaier BC, et al. MicroRNA-24 regulates vascularity after myocardial infarction. Circulation 2011; 124: 720-730.
25. Meloni M, Marchetti M, Garner K,. Local inhibition of microRNA-24 improves reparitive angiogenesis and left ventricule remodelling and function in mice with myocardial infarction. Mol Ther 2013; 21: 1390-1402.
26. Grundmann S, Hans FP, Kinniry S, et al. MicroRNA-100 regulates neovascularization by suppression of mammalian target of rapamycin in endothelial and vascular smooth muscle cells. Circulation 2011; 123: 999-1009.
27. Boon RA, Iekushi K, Lechner S, et al. MicroRNA-34a regulates cardiac ageing and function. Nature 2013; 495: 107-110.
28. Caporali A, Meloni M, Vollenkle C, et al. Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia. Circulation 2011; 123: 282-291.
29. Marshall CJ, Sinclair JC, Thrasher AJ, et al. Bone morphogenetic protein 4 modulates c-Kit expression and differentiation potential in murine embryonic aorta-gonad-mesonephros haematopoiesis in vitro. Br J Haematol 2007; 139: 321-330.
30. Rybtsov S, Sobiesiak M, Taoudi S, et al. Hierarchical organization and early hematopoietic specification of the developing HSC lineage in the AGM region. J Exp Med 2011; 208: 1305-1315.
31. Nimmo R, Ciau-Uitz A, Ruiz-Herguido C, et al. miR-142-3p controls the specification of definitive hemangioblasts during ontogeny. Dev Cell 2013; 26: 237-249.
32. Lu X, Li X, He Q, et al. miR-142-3p regulates the formation and differentiation of hematopoietic stem cells in vertebrates. Cell Res 2013; 23: 1356-1368.
33. Spinetti G, Cordella D, Fortunato O, et al. Global remodeling of the vascular stem cell niche in bone marrow of diabetic patients: Implication of the microRNA-155/FOXO3a signaling pathway. Circ Res 2013; 112: 510-522.
34. Spinetti G, Fortunato O, Caporali A, et al. MicroRNA-15a and microRNA-16 impair human circulating proangiogenic cell functions and are increased in the proangiogenic cells and serum of patients with critical limb ischemia. Circ Res 2013; 112: 335-346.
35. Meng S, Cao JT, Zhang B, et al. Downregulation of microRNA-126 in endothelial progenitor cells from diabetes patients, impairs their functional properties, via target gene Spred-1. J Mol Cell Cardiol 2012; 53: 64-72.
36. Mocharla P, Briand S, Giannotti G, et al. AngiomiR-126 expression and secretion from circulating CD34(+) and CD14(+) PBMCs: Role for proangiogenic effects and alterations in type 2 diabetics. Blood 2013; 121: 226-236.
37. Jakob P, Doerries C, Briand S, et al. Loss of angiomiR-126 and 130a in angiogenic early outgrowth cells from patients with chronic heart failure: Role for impaired in vivo neovascularization and cardiac repair capacity. Circulation 2012; 126: 2962-2975.
38. Iekushi K, Seeger F, Assmus B, et al. Regulation of cardiac microRNAs by bone marrow mononuclear cell therapy in myocardial infarction. Circulation 2012; 125: 1765-1773, S1761-1767.
39. Katare R, Riu F, Mitchell K, et al. Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program involving micro-RNA-132. Circ Res 2011; 109: 894-906.
40. Zhu S, Deng S, Ma Q, et al. MicroRNA-10A* and MicroRNA-21 modulate endothelial progenitor cell senescence via suppressing high-mobility group A2. Circ Res 2013; 112: 152-164.
41. Campagnolo P, Cesselli D, Al Haj Zen A, et al. Human adult vena saphena contains perivascular progenitor cells endowed with clonogenic and proangiogenic potential. Circulation 2010; 121: 1735-1745.
42. Lu SJ, Feng Q, Caballero S, et al. Generation of functional hemangioblasts from human embryonic stem cells. Nat Methods 2007; 4: 501-509.
43. Sone M, Itoh H, Yamahara K, et al. Pathway for differentiation of human embryonic stem cells to vascular cell components and their potential for vascular regeneration. Arterioscler Thromb Vasc Biol 2007; 27: 2127-2134.
44. Robless P, Mikhailidis DP, Stansby GP,. Cilostazol for peripheral arterial disease. Cochrane Database Syst Rev 2007: CD003748.
45. Chen S-J, Chang C-M, Tsai S-K, et al. Functional improvement of focal cerebral ischemia injury by subdural transplantation of induced pluripotent stem cells with fibrin glue. Stem Cells Dev 2011; 19: 1757-1767.
46. Choi KD, Yu J, Smuga-Otto K, et al. Hematopoietic and endothelial differentiation of human induced pluripotent stem cells. Stem Cells 2009; 27: 559-567.
47. Lai WH, Ho JC, Chan YC, et al. Attenuation of hind-limb ischemia in mice with endothelial-like cells derived from different sources of human stem cells. PLoS One 2013; 8: e57876.
48. Kane NM, Howard L, Descamps B, et al. A role for microRNAs 99b, 181a and 181b in the differentiation to vascular endothelial cells from human embryonic stem cells. Stem Cells 2012; 30: 643-654.
49. Kane NM, Meloni M, Spencer HL, et al. Derivation of endothelial cells from human embryonic stem cells by directed differentiation: Analysis of microRNA and angiogenesis in vitro and in vivo. Arterioscler Thromb Vasc Biol 2010; 30: 1389-1397.
50. Chen T, Bai H, Shao Y, et al. Stromal cell-derived factor-1/CXCR4 signaling modifies the capillary-like organization of human embryonic stem cell-derived endothelium in vitro. Stem Cells 2007; 25: 392-401.
51. Kane NM, Howard L, Descamps B, et al. Role of microRNAs 99b, 181a, and 181b in the differentiation of human embryonic stem cells to vascular endothelial cells. Stem Cells 2012; 30: 643-654.
52. Wu F, Yang Z, Li G,. Role of specific microRNAs for endothelial function and angiogenesis. Biochem Biophys Res Commun 2009; 386: 549-553.
53. Ivey K, Muth A, Arnold J, et al. MircoRNA regulation of cell lineages in mouse and human embryonic stem cells. Cell Stem Cell 2008; 2: 219-229.
54. Fish JE, Santoro MM, Morton SU, et al. miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell 2008; 15: 272-284.
55. Treguer K, Heinrich EM, Ohtani K, et al. Role of the microRNA-17-92 cluster in the endothelial differentiation of stem cells. J Vasc Res 2012; 49: 447-460.
56. Small EM, Sutherland LB, Rajagopalan KN, et al. MicroRNA-218 regulates vascular patterning by modulation of slit-robo signaling. Circ Res 2010; 107: 1336-1344.
57. Amatschek S, Kriehuber E, Bauer W, et al. Blood and lymphatic endothelial cell-specific differentiation programs are stringently controlled by the tissue environment. Blood 2007; 109: 4777-4785.
58. Hirakawa S, Hong Y-K, Harvey N, et al. Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells. Am J Pathol 2003; 162: 575-586.
59. Roesli C, Mumprecht V, Neri D, et al. Identification of the surface-accessible, lineage-specific vascular proteome by two-dimensional peptide mapping. FASEB J 2008; 22: 1933-1944.
60. Kazenwadel J, Michael MZ, Harvey NL,. Prox1 expression is negatively regulated by miR-181 in endothelial cells. Blood 2010; 116: 2395-2401.
61. Leslie Pedrioli DM, Karpanen T, Dabouras V, et al. miR-31 functions as a negative regulator of lymphatic vascular lineage-specific differentiation in vitro and vascular development in vivo. Mol Cell Biol 2010; 30: 3620-3634.
62. Porrello ER, Mahmoud AI, Simpson E, et al. Regulation of neonatal and adult mammalian heart regeneration by the miR-15 family. Proc Natl Acad Sci USA 2013; 110: 187-192.
63. Caporali A, Emanueli C,. MicroRNA-503 and the extended microRNA-16 family in angiogenesis. Trends Cardiovasc Med 2011; 21: 162-166.
64. Elmen J, Lindow M, Schutz S, et al. LNA-mediated microRNA silencing in non-human primates. Nature 2008; 452: 896-899.
65. Ebert MS, Neilson JR, Sharp PA,. MicroRNA sponges: Competitive inhibitors of small RNAs in mammalian cells. Nat Methods 2007; 4: 721-726.
66. Hu S, Huang M, Li Z, et al. MicroRNA-210 as a novel therapy for treatment of ischemic heart disease. Circulation 2010; 122: S124-131.
67. Eulalio A, Mano M, Dal Ferro M, et al. Functional screening identifies miRNAs inducing cardiac regeneration. Nature 2012; 492: 376-381.
68. Boon RA, Vickers KC,. Intercellular transport of microRNAs. Arterioscler Thromb Vasc Biol 2013; 33: 186-192.
69. Fasanaro P, D'Alessandra Y, Di Stefano V, et al. MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand ephrin-A3. J Biol Chem 2008; 283: 15878-15883.
70. Yin KJ, Olsen K, Hamblin M, et al. Vascular endothelial cell-specific microRNA-15a inhibits angiogenesis in hindlimb ischemia. J Biol Chem 2012; 287: 27055-27064.
71. Chamorro-Jorganes A, Araldi E, Penalva LO, et al. MicroRNA-16 and MicroRNA-424 regulate cell-autonomous angiogenic functions in endothelial cells via targeting vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1. Arterioscler Thromb Vasc Biol 2011; 31: 2595-2606.
72. Bernardo BC, Gao XM, Winbanks CE, et al. Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function. Proc Natl Acad Sci USA 2012; 109: 17615-17620.
73. Xu Q, Seeger FH, Castillo J, et al. Micro-RNA-34a contributes to the impaired function of bone marrow-derived mononuclear cells from patients with cardiovascular disease. J Am Coll Cardiol 2012; 59: 2107-2117.